Sichuan Kelun Pharmaceutical Co Ltd (002422)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Sichuan Kelun Pharmaceutical Co Ltd (002422) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011328
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compound amino acid injection, alanyl glutamine injection, fructose injection, fructose and sodium chloride injection, compound amino acids, fat emulsion injection, vitamin c and glucose injection, vitamin c and sodium chloride injection, kang fu xin solution and lafutidine capsules. It also offers products to serve parenteral nutrition, digestive system, cardiovascular, antipsychotic, respiratory system, anti-pathogenic microorganisms, and APIs and intermediates. Kelun is headquartered in Chengdu, China.

Sichuan Kelun Pharmaceutical Co Ltd (002422) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deal Details 10
Debt Offering 10
Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 10
Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 11
Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 12
Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 13
Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 14
Acquisition 15
Sichuan Kelun Pharma Acquires Chongzhou Junjian Medical, Medical Packaging Company 15
Sichuan Kelun Pharmaceutical Co Ltd – Key Competitors 16
Sichuan Kelun Pharmaceutical Co Ltd – Key Employees 17
Sichuan Kelun Pharmaceutical Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Key Facts, 2016 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Sichuan Kelun Pharmaceutical Co Ltd, Deals By Market, 2011 to YTD 2017 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 10
Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 11
Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 12
Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 13
Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 14
Sichuan Kelun Pharma Acquires Chongzhou Junjian Medical, Medical Packaging Company 15
Sichuan Kelun Pharmaceutical Co Ltd, Key Competitors 16
Sichuan Kelun Pharmaceutical Co Ltd, Key Employees 17
Sichuan Kelun Pharmaceutical Co Ltd, Subsidiaries 18

★海外企業調査レポート[Sichuan Kelun Pharmaceutical Co Ltd (002422)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Cincinnati Bell Inc (CBB):企業の財務・戦略的SWOT分析
    Cincinnati Bell Inc (CBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Discovery Holdings Limited (DSY):企業の財務・戦略的SWOT分析
    Discovery Holdings Limited (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向
    Aslan Pharmaceuticals Pte Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aslan Pharmaceuticals Pte Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • M3 Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary M3 Biotechnology Inc (M3 Biotech) is a clinical stage biotech company that focuses on regenerative medicine. The company is developing clinical programs for the treatment of Alzheimer, MS, Parkinson and Alzheimerdisease (oral) among others. It utilizes discovery platform and develops small m …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • InvitroCue Ltd (IVQ)-製薬・医療分野:企業M&A・提携分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd is a provider of bio-analytic solutions. The company offers digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image arch …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) operates as a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibati …
  • Maxim Integrated Products Inc (MXIM):企業の財務・戦略的SWOT分析
    Maxim Integrated Products Inc (MXIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • Millennium & Copthorne Hotels Plc:戦略・SWOT・企業財務分析
    Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …
  • SS&C Technologies Holdings Inc.:企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Mikros Systems Corporation:企業の戦略・SWOT・財務分析
    Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Targa Resources Partners LP (NGLS PR A)-エネルギー分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • C&S Wholesale Grocers, Inc.:企業の戦略・SWOT・財務情報
    C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Westdeutsche Immobilien Servicing AG:企業の戦略・SWOT・財務分析
    Westdeutsche Immobilien Servicing AG - Strategy, SWOT and Corporate Finance Report Summary Westdeutsche Immobilien Servicing AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • ISMT Limited:企業の戦略・SWOT・財務情報
    ISMT Limited - Strategy, SWOT and Corporate Finance Report Summary ISMT Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆